Product Images Duloxetine Delayed-release

This is a description of a medication called Duloxetine, which is the generic equivalent of Cymbalta. Each capsule contains 33.7mg of Duloxetine Hydrochloride equivalent to 30mg of Duloxetine. The manufacturer is Breckenridge Pharmaceuticals, Inc. and it is packaged with an expiration date and a lot/batch number. The text also warns that it is illegal to transfer the drug to anyone other than the patient for whom it was prescribed. There are repeated mentions of "Duloxetine Delayed-Release Cap USP 30mg" with varying additional information such as quantity, insurance NDC, lot, batch, and product NDO.*

This appears to be a graph that shows the proportion of patients experiencing relapse over time (in days) from randomization. There are three data points on the x-axis: 0, 20, and 40. The y-axis ranges from 0 to 0.2. The graph includes two lines or curves, one in blue and one in orange, that appear to represent two different treatments or groups of patients. The blue line starts at 0 and gradually increases to approximately 0.15 at 40 days. The orange line starts at 0 and remains relatively flat until around 20 days, after which it increases more rapidly to a maximum of approximately 0.2 at 40 days. There is no information regarding the specific treatments or conditions being studied.*

The text describes a graph showing the percentage of patients who have improved in pain over time (1 week) from a baseline measurement, displayed on an X-axis with markings at 0, 20, and 100, and a Y-axis denoting percent improvement.*